drugset / Trial / NCT01809886
Reversal With Sugammadex From Deep Neuromuscular Blockade Induced by Rocuronium in Children: Randomised Clinical Trial
Phase 3
Completed
100 enrolled
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Hospital Universitario Santa Maria del Rosell · collabHospital Universitario Virgen de la Arrixaca · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this clinical trial is to prove that the administration of sugammadex at a dose of 4 mg/kg for counteracting deep blockage \[without train-of-four (TOF) ratio response and post-tetanic count (PTC) \< of 2 induced and maintained with Rocuronium in pediatric patients for short-term elective surgery.
Timeline
- Start
- 2011-10
- Primary completion
- 2013-10
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Neostigmine | Other / unclassified | 0.05 mg/kg | — |
| Subject | Sugammadex | Other / unclassified | 4 mg/kg | — |
| Background | Atropine | Other / unclassified | 0.025 mg/kg | — |
Indications
No indication recorded.